Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06762405
Title PRODIGE 90 - (FFCD 2204) Neoadjuvant Dostarlimab with Short Course Radiotherapy in a Watch-and-wait Strategy for Microsatellite Unstable or Mismatch Repair-deficient Locally Advanced Rectal Cancer Patients (PREDIR-NEOREC)
Acronym PREDIR-NEOREC
Recruitment Not yet recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Centre Hospitalier Universitaire Dijon
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Additional content available in CKB BOOST